New Cancer Drugs Help Fewer Than 2% of Patients

  • New Cancer Drugs Help Fewer Than 2% of Patients

    Posted by IMA-HelenT on April 17, 2026 at 8:10 am EDT

    I was listening to a podcast today discussing a real-world prospective study on repurposed drugs in cancer.

    A very sad comment came from a man that shared that he lost his 41-year-old wife to cancer. They threw every standard treatment available at her, and her quality of life before she died was so awful… but repurposed drugs were never even mentioned. Not once. You can imagine how that feels now.

    What made it hit even harder was the data being discussed. The study showed around 84% of patients experienced either stable disease or a reduction in tumour growth—real-world outcomes, not theory.

    Then this new review from the IMA highlights something difficult to ignore: most newly FDA approved cancer drugs benefit fewer than 2% of patients, and many are targeted at very small patient groups.

    Read the full review here: https://imahealth.org/new-review-finds-most-new-cancer-drugs-help-fewer-than-2-of-patients/

    So on one side, you have a system producing highly targeted drugs with very limited reach… and on the other, existing, widely available drugs showing meaningful outcomes in a large proportion of patients, but still rarely part of the conversation.

    Let’s hope that as we see more and more information getting onto different channels, people can start to demand this from their doctors, perhaps that drives the change we so desperately need to see in cancer treatment.

    IMA-HelenT replied 2 weeks, 6 days ago 4 Members · 8 Replies
  • 8 Replies
  • Sophos

    Member
    April 18, 2026 at 12:37 am EDT

    You said:

    “Most newly FDA approved cancer drugs benefit fewer than 2% of patients, and many are targeted at very small patient groups.”

    One simple explanation may be attributed to little known fact that “FDA” stands for Federal Depopulation Agency.

    Away with these agencies for good! They serve no useful functions other than employment for the low lifers.

    • IMA-HelenT

      Organizer
      April 18, 2026 at 9:52 am EDT

      It certainly seems that way !

  • drspc

    Member
    April 19, 2026 at 1:16 pm EDT

    Sadly most docs want to follow what they have been taught.

    If they don’t follow protocol they might have to suffer the consequences

    • IMA-HelenT

      Organizer
      April 19, 2026 at 2:46 pm EDT

      True…and that’s exactly why organisations like the Independent Medical Alliance are so important right now: helping doctors navigate a more open and honest way of practicing medicine.

  • Christopher Robb

    Member
    April 28, 2026 at 8:08 am EDT

    Hi – I am from the UK, I have a 45 year old daughter suffering from stage 4 colon cancer which went to the liver. She had extensive removal of the colon and also the infected liver. since then she has had various conventional treatments and has been trying to find alternatives. She is in a good position at the moment, having sort alternative treatment with a Kinesiologist, who we think has kept her together plus sorted her diet (which was not too bad). Her Blood Markers have been up and down like a yo yo, and currently are the lowest she has had and close to a normal count. She is thinking it might be the chance to change horses and having seen and read about Dr Maliks cancer pathway, we are able to source (the 5 plus Ivermectin) all the drugs easily from India.

    I personally used Ivermectin when suffering from a very low blood oxygen levels of 89 to 90 following my one and only mRNA Pfizer gene therapy – which has given me days of no energy for 4 years…. The ivermectin restored my Blood oxygen to 98 within a week – astounding – as my hospital doctor could not understand with a high red cell count, why I had the problem. They gave no solution other than having oxygen to hand!

    My problem is that there are no practitioners in the UK who could supervise the treatment – dosage etc. I was hoping that the IMA would be able to advise on this.

    I look forward to hearing from anyone who could help with this.

  • Christopher Robb

    Member
    April 28, 2026 at 3:29 pm EDT

    Thanks for that detailed information.i will start analysing it tomorrow.

    • IMA-HelenT

      Organizer
      April 29, 2026 at 7:10 am EDT

      👍

Log in to reply.